Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
BioVista Inc. Graham Anthony ,working with pharma companies to help them get best out of their own drugs




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: BioVista Inc. Graham Anthony ,working with pharma companies to help them get best out of their own drugs
Released on: November 16, 2011. © PharmaTelevision Ltd
Visitors: You are watching a 5 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Participants
  • Company
In this episode of PharmaTelevision News Review, Fintan Walton talks to Graham Anthouny, CFO of BioVista Inc.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
USP and science of Biovista
Fintan Walton:
Hello and welcome to PharmaTelevision News Review here at BioPharm America in Boston, in September 2011. On this show I have Graham Anthony, who is Chief Financial Officer of a company called Biovista which is based both in Charlottesville, Virginia and also in Athens, Greece. Welcome to the show.
Graham Anthony:
Thank you very much, it's a pleasure to be here.
Fintan Walton:
Good. And Graham, could you tell us what is Biovista? What is the company and what is its mission?
Graham Anthony:
Well Biovista is at its sort of basic level a collection of the hard work and knowledge that people who've done to date, and what we have done is hopefully done a better way to collect 00.00.53 and make access for that information and use it in productive ways to advance science.
Fintan Walton:
Right, so that's very succinct, I am sure it is a little bit more depth to it than now you've just said?
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Fintan Walton
Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).
Graham Anthony
Chief Financial Officer
Graham Anthony is currently Biovista's Chief Financial Officer and Chairman of its Advisory Board. In this role, Graham will help Biovista build and monetize its IP estate, assess new business opportunities and coordinate Biovista's response to future investment interest. Graham recently led Biovista's first outside round of funding, which was completed in 7 days and 4x oversubscribed. Since 2000, both as an advisor and as a principal, Graham has assisted various firms in completing over 30 fundraisings, acquisitions & divestitures in a diverse range of industries. Recent investments include: TeamScreen, a business services firm using advanced web technologies to reduce costs & Greenlight Energy, a Wind Energy firm recently sold to BP. Past clients include private equity firms: The Jordan Company, Republic Financial Corporation, Royal Palm Capital Partners, Quaker Capital Management & Falcon Mezzanine Investments. Since 2000, Graham has been a speaker on Mergers & Acquisitions and Benchmarking to groups ranging from ISPCON (the Internet Services Provider Conference) to the National Pest Management Association to the American Wind Energy Association, where he was author of the 2005, 2006 and 2007 studies on "Value Creation at Each Stage of the Wind Development Process." In the 1990s, Graham worked on $4 Billion of Senior Debt, Subordinated Debt & Equity offerings at Bankers Trust (now Deutsche Bank) in their Leveraged Finance Department. Early in his career, Graham founded, ran and sold two businesses: a small manufacturing firm and a regional newspaper. Graham received his MBA from the University of Virginia's Darden School of Business, where he was awarded a Batten Fellowship. He holds a BA in English from the University of Virginia's College of Arts & Sciences.
PharmaVentures
PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.
Biovista
Biovista began operations in 1996 with the initial aim of supplying business intelligence products and services to the life sciences industry. Since then, Biovista developed a novel, unique and state-of-the art technology that has allowed Biovista to offer distinct value in basic research, clinical development and consumer health, in addition to supporting own internal efforts in finding new uses for existing drugs. Biovista's customer base includes pharmaceutical and biotechnology companies, academic institutions, and research and government organizations in the US, EU and Asia.